$1.25
0[0.00%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$1.24
-0.0100[-0.80%]
| Open- | Close- |
| Vol / Avg.0 / 2.332M | Mkt Cap142.943M |
| Day Range- - - | 52 Wk Range1.110 - 6.010 |
Karyopharm Therapeutics Stock (NASDAQ:KPTI), Key Statistics
Karyopharm Therapeutics Stock (NASDAQ: KPTI) analysis, key statistics.
Valuation Measures
Enterprise Value
84.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.85
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-116.8%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.62
Tangible Book value per share
-0.62
Total Liabilities (Quarterly)
369.1M
Total Assets
297.8M
Total Liabilities
369.1M
Profitability
Net income Growth
- -
Gross Margin
96.82%
Net Margin
-86.83%
EBIT Margin
-71.1%
EBITDA Margin
-70.88%
Operating Margin
-78.7%
Karyopharm Therapeutics Stock (NASDAQ:KPTI), Key Statistics
Karyopharm Therapeutics Stock (NASDAQ: KPTI) analysis, key statistics.
Valuation Measures
Enterprise Value
84.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.85
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-116.8%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.62
Tangible Book value per share
-0.62
Total Liabilities (Quarterly)
369.1M
Total Assets
297.8M
Total Liabilities
369.1M
Profitability
Net income Growth
- -
Gross Margin
96.82%
Net Margin
-86.83%
EBIT Margin
-71.1%
EBITDA Margin
-70.88%
Operating Margin
-78.7%
Karyopharm Therapeutics Stock (NASDAQ:KPTI), Key Statistics
Karyopharm Therapeutics Stock (NASDAQ: KPTI) analysis, key statistics.
Valuation Measures
Enterprise Value
84.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.85
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-116.8%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.62
Tangible Book value per share
-0.62
Total Liabilities (Quarterly)
369.1M
Total Assets
297.8M
Total Liabilities
369.1M
Profitability
Net income Growth
- -
Gross Margin
96.82%
Net Margin
-86.83%
EBIT Margin
-71.1%
EBITDA Margin
-70.88%
Operating Margin
-78.7%
Karyopharm Therapeutics Stock (NASDAQ:KPTI), Key Statistics
Karyopharm Therapeutics Stock (NASDAQ: KPTI) analysis, key statistics.
Valuation Measures
Enterprise Value
84.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.85
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-116.8%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.62
Tangible Book value per share
-0.62
Total Liabilities (Quarterly)
369.1M
Total Assets
297.8M
Total Liabilities
369.1M
Profitability
Net income Growth
- -
Gross Margin
96.82%
Net Margin
-86.83%
EBIT Margin
-71.1%
EBITDA Margin
-70.88%
Operating Margin
-78.7%
Karyopharm Therapeutics Stock (NASDAQ:KPTI), Key Statistics
Karyopharm Therapeutics Stock (NASDAQ: KPTI) analysis, key statistics.
Valuation Measures
Enterprise Value
84.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.85
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-116.8%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.62
Tangible Book value per share
-0.62
Total Liabilities (Quarterly)
369.1M
Total Assets
297.8M
Total Liabilities
369.1M
Profitability
Net income Growth
- -
Gross Margin
96.82%
Net Margin
-86.83%
EBIT Margin
-71.1%
EBITDA Margin
-70.88%
Operating Margin
-78.7%
Karyopharm Therapeutics Stock (NASDAQ:KPTI), Key Statistics
Karyopharm Therapeutics Stock (NASDAQ: KPTI) analysis, key statistics.
Valuation Measures
Enterprise Value
84.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.85
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-116.8%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.62
Tangible Book value per share
-0.62
Total Liabilities (Quarterly)
369.1M
Total Assets
297.8M
Total Liabilities
369.1M
Profitability
Net income Growth
- -
Gross Margin
96.82%
Net Margin
-86.83%
EBIT Margin
-71.1%
EBITDA Margin
-70.88%
Operating Margin
-78.7%
Karyopharm Therapeutics Stock (NASDAQ:KPTI), Key Statistics
Karyopharm Therapeutics Stock (NASDAQ: KPTI) analysis, key statistics.
Valuation Measures
Enterprise Value
84.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.85
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-116.8%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.62
Tangible Book value per share
-0.62
Total Liabilities (Quarterly)
369.1M
Total Assets
297.8M
Total Liabilities
369.1M
Profitability
Net income Growth
- -
Gross Margin
96.82%
Net Margin
-86.83%
EBIT Margin
-71.1%
EBITDA Margin
-70.88%
Operating Margin
-78.7%
Karyopharm Therapeutics Stock (NASDAQ:KPTI), Key Statistics
Karyopharm Therapeutics Stock (NASDAQ: KPTI) analysis, key statistics.
Valuation Measures
Enterprise Value
84.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.85
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-116.8%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.62
Tangible Book value per share
-0.62
Total Liabilities (Quarterly)
369.1M
Total Assets
297.8M
Total Liabilities
369.1M
Profitability
Net income Growth
- -
Gross Margin
96.82%
Net Margin
-86.83%
EBIT Margin
-71.1%
EBITDA Margin
-70.88%
Operating Margin
-78.7%
Karyopharm Therapeutics Stock (NASDAQ:KPTI), Key Statistics
Karyopharm Therapeutics Stock (NASDAQ: KPTI) analysis, key statistics.
Valuation Measures
Enterprise Value
84.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.85
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-116.8%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.62
Tangible Book value per share
-0.62
Total Liabilities (Quarterly)
369.1M
Total Assets
297.8M
Total Liabilities
369.1M
Profitability
Net income Growth
- -
Gross Margin
96.82%
Net Margin
-86.83%
EBIT Margin
-71.1%
EBITDA Margin
-70.88%
Operating Margin
-78.7%